Pfizer (PFE) stock news today
Latest Pfizer (PFE) news, a Salud company: AI summaries, market impact and related companies.
In the last 7 days, 6 stories about Pfizer: 0 on agreements, 0 on disputes and 6 informational.
S&P 500
Latest news
Summary and analysis generated with AI from the original story.
- Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
Summary (AI): Pfizer will present new clinical data on its established oncology treatments and late-stage candidates during the ESMO congress in Madrid. The pharmaceutical company aims to strengthen scientific evidence for current medicines and advance experimental therapie Yahoo Finance - Global Cyclic Peptide Library Market Outlook and Forecast, 2026-2032 - AI-Enabled Discovery Fuels 16.32% CAGR Toward USD 9.86 Billion as PeptiDream, Bicycle Therapeutics, Pfizer and Roche Advance Competition
Summary (AI): The global cyclic peptide library market is projected to grow at a CAGR of 16.32%, reaching a valuation of USD 9.86 billion by 2032. Companies such as PeptiDream, Bicycle Therapeutics, Pfizer, and Roche are highlighted as key players in a sector that integrate Yahoo Finance - Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
Summary (AI): The article analyzes the concentration risks of Pfizer and Gilead Sciences, contrasting the challenges of their respective product portfolios. Pfizer faces the loss of patent exclusivity, while Gilead shows significant dependence on its HIV franchise despite i Yahoo Finance - Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside?
Summary (AI): Pfizer and Thermo Fisher Scientific are undergoing financial recovery processes following the post-pandemic period, showing divergent results. While Thermo Fisher is experiencing positive operational momentum due to increased activity in life-sciences markets, Yahoo Finance - Pfizer (PFE) equilibra la oportunidad de precios globales con un nuevo reparto de ingresos
Summary (AI): Pfizer ha acordado compartir con el Departamento de Salud y Servicios Sociales de EE. UU. una parte de los ingresos netos adicionales obtenidos por el aumento de precios de medicamentos en el extranjero. Este acuerdo de reparto de ingresos, que estará vigente Yahoo Finance - What Could Pfizer (PFE) Unlock From Faster FDA Reviews And Orphan Drug Growth? Yahoo Finance
This information describes events and possible links between companies. It is not a personal recommendation or an instruction to buy, sell or hold securities. Automated conclusions may be wrong or out of date: check official sources and authorised professionals before deciding.